000			02042 a2200541 4500
005			20250517132024.0
264		0	_c20180314
008			201803s 0 0 eng d
022			_a1527-9995
024	7		_a10.1016/j.urology.2016.12.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aShintani, Terumichi
245	0	0	_aThe Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells. _h[electronic resource]
260			_bUrology _cMar 2017
300			_a169.e7-169.e13 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnilides _xpharmacology
650	0	4	_aBlotting, Western
650	0	4	_aCell Count
650	0	4	_aCell Line, Tumor _xdrug effects
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHepatocyte Growth Factor _xbiosynthesis
650	0	4	_aHumans
650	0	4	_aMatrix Metalloproteinase 1 _xbiosynthesis
650	0	4	_aNeoplasm Invasiveness _xgenetics
650	0	4	_aProtein Array Analysis
650	0	4	_aProto-Oncogene Proteins c-met _xbiosynthesis
650	0	4	_aPyridines _xpharmacology
650	0	4	_aRNA, Neoplasm _xgenetics
650	0	4	_aReceptor Protein-Tyrosine Kinases
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aSignal Transduction
650	0	4	_aUrinary Bladder _xdrug effects
650	0	4	_aUrinary Bladder Neoplasms _xdrug therapy
700	1		_aKusuhara, Yoshito
700	1		_aDaizumoto, Kei
700	1		_aDondoo, Tsogt-Ochir
700	1		_aYamamoto, Hiroki
700	1		_aMori, Hidehisa
700	1		_aFukawa, Tomoya
700	1		_aNakatsuji, Hiroyoshi
700	1		_aFukumori, Tomoharu
700	1		_aTakahashi, Masayuki
700	1		_aKanayama, Hiroomi
773	0		_tUrology _gvol. 101 _gp. 169.e7-169.e13
856	4	0	_uhttps://doi.org/10.1016/j.urology.2016.12.006 _zAvailable from publisher's website
999			_c26729483 _d26729483